Recombinant Human TFF1 Protein, CF
Recombinant Human TFF1 Protein, CF Summary
Glu25-Phe84 with a C-terminal 6-His tag
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 500 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Trefoil Factor 1 (TFF1), also known as pS2, is one of three structurally related secreted proteins that contain trefoil domains. These domains adopt a three-leaved conformation held together by conserved intrachain disulfide bonds. TFF1 is an approximately 7 kDa peptide that plays an important role in epithelial regeneration and wound healing (1). Mature human TFF1 shares 67% amino acid sequence identity with mouse and rat TFF1. It is expressed by goblet cells of the gastric and intestinal mucosa and by conjunctival goblet cells (2-5). TFF1 is a copper-binding protein that can form disulfide-linked homodimers, associate into disulfide-linked complexes with Gastrokine 2, and form non-covalent complexes with the mucin MUC5AC (4, 6-8). Copper enhances TFF1 homodimerization as well as its ability to promote epithelial cell motility, wound healing, and the colonization of H. pylori in stomach and colon epithelia (9, 10). TFF1 is down-regulated during the progression from gastritis to gastric dysplasia to gastric cancer, although it is up-regulated in breast and prostate cancers (11-13). TFF1 inhibits the formation of calcium oxalate crystals, and its excretion in the urine is reduced in patients with kidney stones (14).
- Kjellev, S. (2009) Cell. Mol. Life Sci. 66:1350.
- Madsen, J. et al. (2007) J. Histochem. Cytochem. 55:505.
- Rio, M.C. et al. (1988) Science 241:705.
- Newton, J.L. et al. (2000) Gut 46:312.
- Langer, G. et al. (1999) Invest. Opthalmol. Visual Sci. 40:2220.
- Chadwick, M.P. et al. (1997) Biochem. Biophys. Res. Commun. 327:117.
- Westley, B.R. et al. (2005) Biochemistry 44:7967.
- Ruchaud-Sparagano, M.H. et al. (2004) Cell. Mol. Life Sci. 61:1946.
- Tosco, A. et al. (2010) Cell. Mol. Life Sci. 67:1943.
- Montefusco, S. et al. (2013) PLoS ONE 8:e79455.
- Soutto, M. et al. (2011) J. Clin. Invest. 121:1753.
- Kida, N. et al. (1989) Cancer Res. 49:3494.
- Vestergaard, E.M. et al. (2006) Clin. Cancer Res. 12:807.
- Chutipongtanate, S. et al. (2005) J. Clin. Invest. 115:3613.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human TFF1 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human TFF1 Protein, CF and earn rewards!
Have you used Recombinant Human TFF1 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image